This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Women's Health, Other  • Alert me on articles by topic

Further Findings From the Women’s Health Initiative

Diana B. Petitti, MD

JAMA. 2005;294:245-246.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In July 2002, initial results from the Women’s Health Initiative (WHI) randomized trial of combined estrogen plus progestin hormone therapy (CEE + MPA)¹ and follow-up data from the Heart Estrogen/progestin Replacement Study (HERS)² were published within weeks of each other. The increased risks associated with CEE + MPA therapy for postmenopausal women drew wide attention not only among the clinical professions, but also among the media, including front-page articles in major newspapers, feature stories in major weekly news magazines, and coverage by virtually all major television news programs. Neither women taking hormones nor their physicians could escape the media message: postmenopausal hormone therapy is dangerous.

Many women taking hormones were urged by their physicians to stop taking these medications immediately or decided to stop taking them on their own. At the time, anecdote, not evidence, answered women’s question, "What can I expect?" In this issue of . . . [Full Text of this Article]

Author Affiliation: Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena.

RELATED ARTICLE

Symptom Experience After Discontinuing Use of Estrogen Plus Progestin
Judith K. Ockene, David H. Barad, Barbara B. Cochrane, Joseph C. Larson, Margery Gass, Sylvia Wassertheil-Smoller, JoAnn E. Manson, Vanessa M. Barnabei, Dorothy S. Lane, Robert G. Brzyski, Milagros C. Rosal, Judy Wylie-Rosett, and Jennifer Hays
JAMA. 2005;294(2):183-193.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Statins for infection and sepsis: a systematic review of the clinical evidence
Falagas et al.
J Antimicrob Chemother 2008;61:774-785.
ABSTRACT | FULL TEXT  

Menopausal Symptoms Are Common After Stopping Hormone Therapy
Journal Watch Dermatology 2005;2005:8-8.
FULL TEXT  

Menopausal Symptoms Are Common After Stopping Hormone Therapy
JWatch General 2005;2005:5-5.
FULL TEXT